MUC5AC and nonpapillary renal cell carcinoma: Moreover, MUC5AC expression might be contributed to risk stratification of ccRCC patients with TNM stage III+IV or Fuhrman grade 3 or 4 for OS and RFS analysis (Figure 2 and 3).